Browse studies

Find your next paid study

364 recruiting studies matching your filters

A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (WHO Group 3)

The purpose of this study is to find out if L606 is safe and if it helps people with high blood pressure in the lungs (pulmonary hypertension) caused by inters…

Pulmonary Hypertension Due to Lung Disease (Disorder)

Estimated

~$10 – $8,750

Liquidia Technologies, Inc.NCT07285655

Phase 1

A Phase Ic, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, and Activity of Inhaled GDC-6988 in Patients With Muco-obstructive Disease

This study evaluates the safety, tolerability, and activity of inhaled GDC-6988 in participants with muco-obstructive disease.

Non-cystic Fibrosis BronchiectasisChronic Obstructive Pulmonary Disease

Estimated

~$10 – $8,750

Genentech, Inc.NCT06603246

Phase 2

A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Determine the Safety and Efficacy of Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed …

Idiopathic Pulmonary Fibrosis

Estimated

~$10 – $8,750

Cumberland PharmaceuticalsNCT05571059

Phase 2

An Open-Label, Phase 2 Study Evaluating the Safety of Mosliciguat in Combination With Inhaled Treprostinil in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease

This is a Phase 2, open-label, multi-center clinical study to evaluate the safety and tolerability of inhaled mosliciguat in participants with pulmonary hypert…

Pulmonary HypertensionInterstitial Lung Disease (ILD)Lung Diseases+3 more

Estimated

~$10 – $8,750

Pulmovant, Inc.NCT07333183

Observational

MOMENTOUS Study (iMpact Of an Ecg ai ModEl oN The Diagnosis Of pUlmonary hypertenSion)

MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with intersti…

Pulmonary HypertensionInterstitial Lung Disease (ILD)

Estimated

~$10 – $7,500

Tempus AINCT06911632

A Multicenter Study of the Impact of a COPD Identification and Referral System on Patient Follow Up and Outcomes After an Acute COPD Exacerbation Resulting in an Emergency Department Visit or Hospitalization

The goal of this study is to evaluate the impact of implementing an AI-enabled clinical workflow tool (Viz COPD) on respiratory specialist follow up and clinic…

COPD (Chronic Obstructive Pulmonary Disease)

Estimated

~$10 – $1,050

Viz.ai, Inc.NCT07118306

The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry

The STRIDE Registry will evaluate the real-world effectiveness and safety of dupilumab in participants with COPD. The primary objective is to describe characte…

COPD (Chronic Obstructive Pulmonary Disease)

Randomized Clinical Trial of the Application of TrachPhone HME and the Impact on Patient Satisfaction for Tracheostomized Head and Neck Cancer Patients

This study is being conducted at Tampa General Hospital. This study aims to evaluate the effectiveness of TrachPhone Heat Moisture Exchange (HME) on both patie…

Patient SatisfactionPulmonary Rehabilitation

Estimated

~$10 – $6,250

University of South FloridaNCT07798414

Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass

Patients with pulmonary arterial hypertension (PAH) are at increased risk of muscle loss and decreased physical activity. This study will aim to (1) understand…

Pulmonary Hypertension

Estimated

~$10 – $750

University of PennsylvaniaNCT07132788

Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis

The purposes of this study are: * to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; * to de…

Pulmonary Fibrosis

Estimated

~$10 – $750

University of PittsburghNCT00258570

Phase 2

AN INTERVENTIONAL PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, THIRD PARTY-UNBLINDED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF PF-07275315 IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. COPD is a co…

Moderate to Severe Chronic Obstructive Pulmonary Disease

Evaluating the Efficacy and Safety of Saline Irrigation as an Add-On Therapy for Retained Pleural Infections (LYTICS +)

The purpose of this protocol is to conduct a pilot prospective non-blind clinical trial to evaluate the efficacy and safety of a novel saline irrigation techni…

Pleural Effusion Associated With Pulmonary InfectionPleural Effusion DisorderPleural Effusions

Estimated

~$10 – $6,250

Beth Israel Deaconess Medical CenterNCT06713382